Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
MiNK Therapeutics, Inc. market cap for the quarter ending 2026-08-11 was $57.15M, a 10.89% decline year-over-year.
MiNK Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $60.96M.
MiNK Therapeutics, Inc. market cap for the quarter ending 2026-05-13 was $55.82M, a 84.29% increase year-over-year.
MiNK Therapeutics, Inc. market cap for the quarter ending 2026-03-27 was $55.29M, a 74.70% increase year-over-year.
MiNK Therapeutics, Inc. market cap for fiscal 2026 was $57.15M.
MiNK Therapeutics, Inc. market cap for fiscal 2025 was $52.5M, a 90.06% increase from fiscal 2024.
MiNK Therapeutics, Inc. market cap for fiscal 2024 was $27.62M, a 25.39% decline from fiscal 2023.
MiNK Therapeutics, Inc. market cap for fiscal 2023 was $37.02M, a 95.81% decline from fiscal 2022.